Skip Content
You are currently on the new version of our website. Access the old version .

106 Results Found

  • Review
  • Open Access
7 Citations
3,698 Views
16 Pages

16 December 2021

Increasing evidence has demonstrated the functional roles of miRNAs and lncRNAs in lymphoma onset and progression, either by acting as tumor-promoting ncRNAs or as tumor suppressors, emphasizing their appeal as lymphoma therapeutics. In fact, their i...

  • Review
  • Open Access
10 Citations
5,546 Views
36 Pages

(In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers

  • Maja Sabol,
  • Jean Calleja-Agius,
  • Riccardo Di Fiore,
  • Sherif Suleiman,
  • Sureyya Ozcan,
  • Mark P. Ward and
  • Petar Ozretić

9 October 2021

Rare ovarian cancers (ROCs) are OCs with an annual incidence of fewer than 6 cases per 100,000 women. They affect women of all ages, but due to their low incidence and the potential clinical inexperience in management, there can be a delay in diagnos...

  • Review
  • Open Access
4 Citations
1,527 Views
21 Pages

Novel Biological Strategies for Melanoma Therapy: A Focus on lncRNAs and Their Targeting

  • Francesca Maria Orlandella,
  • Rosaria Arcone,
  • Neila Luciano,
  • Giuliana Salvatore and
  • Maria Letizia Motti

9 April 2025

Increasing evidence revealed that restoring the correct expression of lncRNAs could have implications in the management of melanoma patients. In this context, here, we aim to dissect the main characteristics of lncRNAs altered in melanoma and their c...

  • Review
  • Open Access
14 Citations
4,334 Views
15 Pages

LncRNA MORT (ZNF667-AS1) in Cancer—Is There a Possible Role in Gynecological Malignancies?

  • Riccardo Di Fiore,
  • Sherif Suleiman,
  • Rosa Drago-Ferrante,
  • Ana Felix,
  • Sharon A. O’Toole,
  • John J. O’Leary,
  • Mark P. Ward,
  • James Beirne,
  • Angel Yordanov and
  • Jean Calleja-Agius
  • + 4 authors

Gynecological cancers (GCs) are currently among the major threats to female health. Moreover, there are different histologic subtypes of these cancers, which are defined as ‘rare’ due to an annual incidence of <6 per 100,000 women. The majority of...

  • Review
  • Open Access
10 Citations
6,891 Views
16 Pages

An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma

  • Riccardo Di Fiore,
  • Sherif Suleiman,
  • Ana Felix,
  • Sharon A. O’Toole,
  • John J. O’Leary,
  • Mark P. Ward,
  • James Beirne,
  • Maja Sabol,
  • Petar Ozretić and
  • Jean Calleja-Agius
  • + 9 authors

Choriocarcinoma (CC), a subtype of trophoblastic disease, is a rare and highly aggressive neoplasm. There are two main CC subtypes: gestational and non-gestational, (so called when it develops as a component of a germ cell tumor or is related to a so...

  • Article
  • Open Access
13 Citations
3,997 Views
17 Pages

Triple negative breast cancer (TNBC) represents a diverse group of cancers based on their gene expression profiles. While the current mRNA-based classification of TNBC has contributed to our understanding of the heterogeneity of this disease, whether...

  • Review
  • Open Access
126 Citations
11,007 Views
21 Pages

15 May 2020

Long non-coding RNA (lncRNA), which is a kind of noncoding RNA, is generally characterized as being more than 200 nucleotide transcripts in length. LncRNAs exhibit many biological activities, including, but not limited to, cancer development. In this...

  • Review
  • Open Access
1 Citations
2,109 Views
26 Pages

An Emerging Role of Long Noncoding RNAs as Novel Biomarkers for Breast Cancer Metastasis

  • Kamila Derlatka,
  • Marika Kulczycka,
  • Monika Prendecka-Wróbel,
  • Iwona Homa-Mlak and
  • Teresa Małecka-Massalska

30 July 2024

Breast cancer is a leading cause of cancer-related deaths among women both worldwide and in Poland. Consequently, ensuring equitable access to diagnostic tests for all populations is crucial, alongside the urgent need to develop new, minimally invasi...

  • Review
  • Open Access
9 Citations
3,429 Views
19 Pages

Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease

  • Jorge Infante-Menéndez,
  • Paula González-López,
  • Raquel Huertas-Lárez,
  • Almudena Gómez-Hernández and
  • Óscar Escribano

24 January 2023

Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for the...

  • Review
  • Open Access
13 Citations
3,320 Views
21 Pages

The Role of lncRNAs in the Pathobiology and Clinical Behavior of Multiple Myeloma

  • Arantxa Carrasco-León,
  • Ane Amundarain,
  • Nahia Gómez-Echarte,
  • Felipe Prósper and
  • Xabier Agirre

20 April 2021

MM is a hematological neoplasm that is still considered an incurable disease. Besides established genetic alterations, recent studies have shown that MM pathogenesis is also characterized by epigenetic aberrations, such as the gain of de novo active...

  • Article
  • Open Access
2 Citations
2,197 Views
13 Pages

Association of Long Noncoding RNA Expression Signatures with Stress-Induced Myocardial Perfusion Defects

  • Yu-Chieh Chang,
  • Jun-Ting Liou,
  • Yu-Min Peng,
  • Guan-Jun Chen,
  • Chien-Yu Lin and
  • Chin-An Yang

Stress-induced myocardial perfusion defects found in dipyridamole–thallium-201 single-photon emission computed tomography imaging may indicate vascular perfusion abnormalities and risk of obstructive or nonobstructive coronary heart disease. Be...

  • Review
  • Open Access
36 Citations
6,688 Views
20 Pages

20 March 2020

Treatment decisions for breast cancer are based on staging and hormone receptor expression and include chemotherapies and endocrine therapy. While effective in many cases, some breast cancers are resistant to therapy, metastasize and recur, leading t...

  • Article
  • Open Access
1,860 Views
34 Pages

Identification of Genomic Instability-Associated LncRNAs as Potential Therapeutic Targets in Lung Adenocarcinoma

  • Vanessa G. P. Souza,
  • Katya H. Benard,
  • Greg L. Stewart,
  • Katey S. S. Enfield and
  • Wan L. Lam

15 March 2025

Background/Objectives: Non-small cell lung cancer (NSCLC) is the most common type of cancer, with lung adenocarcinoma (LUAD) as the predominant subtype. Despite advancements in targeted therapies, many NSCLC patients still experience poor outcomes du...

  • Review
  • Open Access
44 Citations
13,447 Views
37 Pages

Long Non-Coding RNAs in Haematological Malignancies

  • Andoni Garitano-Trojaola,
  • Xabier Agirre,
  • Felipe Prósper and
  • Puri Fortes

24 July 2013

Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides in length. LncRNAs are as diverse as mRNAs and they normally share the same biosynthetic machinery based on RNA polymerase II, splicing and polyadenylation. However, lncR...

  • Review
  • Open Access
28 Citations
5,286 Views
13 Pages

The Roles Played by Long Non-Coding RNAs in Glioma Resistance

  • Yeonsoo Chae,
  • Jungwook Roh and
  • Wanyeon Kim

Glioma originates in the central nervous system and is classified based on both histological features and molecular genetic characteristics. Long non-coding RNAs (lncRNAs) are longer than 200 nucleotides and are known to regulate tumorigenesis and tu...

  • Review
  • Open Access
12 Citations
2,818 Views
16 Pages

Retinopathy refers to disorders that affect the retina of the eye, which are frequently caused by damage to the retina’s vascular system. This causes leakage, proliferation, or overgrowth of blood vessels through the retina, which can lead to r...

  • Article
  • Open Access
7 Citations
3,740 Views
20 Pages

Target Enrichment Enables the Discovery of lncRNAs with Somatic Mutations or Altered Expression in Paraffin-Embedded Colorectal Cancer Samples

  • Susana Iraola-Guzmán,
  • Anna Brunet-Vega,
  • Cinta Pegueroles,
  • Ester Saus,
  • Hrant Hovhannisyan,
  • Alex Casalots,
  • Carles Pericay and
  • Toni Gabaldón

1 October 2020

Long non-coding RNAs (lncRNAs) play important roles in cancer and are potential new biomarkers or targets for therapy. However, given the low and tissue-specific expression of lncRNAs, linking these molecules to particular cancer types and processes...

  • Feature Paper
  • Review
  • Open Access
29 Citations
5,102 Views
23 Pages

Long, Noncoding RNA Dysregulation in Glioblastoma

  • Patrick A. DeSouza,
  • Xuan Qu,
  • Hao Chen,
  • Bhuvic Patel,
  • Christopher A. Maher and
  • Albert H. Kim

31 March 2021

Transcription occurs across more than 70% of the human genome and more than half of currently annotated genes produce functional noncoding RNAs. Of these transcripts, the majority—long, noncoding RNAs (lncRNAs)—are greater than 200 nucleotides in len...

  • Review
  • Open Access
56 Citations
6,704 Views
20 Pages

Exploring the Roles of lncRNAs in GBM Pathophysiology and Their Therapeutic Potential

  • Christian T. Stackhouse,
  • G. Yancey Gillespie and
  • Christopher D. Willey

28 October 2020

Glioblastoma (GBM) remains the most devastating primary central nervous system malignancy with a median survival of around 15 months. The past decades of research have not yielded significant advancements in the treatment of GBM. In that same time, a...

  • Review
  • Open Access
7 Citations
3,156 Views
16 Pages

Role of Macrophage lncRNAs in Mediating Inflammatory Processes in Atherosclerosis and Sepsis

  • Hyeung-Seob Shin,
  • Jae-Joon Shin,
  • Jeongkwang Park,
  • Imene Arab,
  • Kyoungho Suk and
  • Won-Ha Lee

Long noncoding RNAs (lncRNAs) are molecules >200 bases in length without protein-coding functions implicated in signal transduction and gene expression regulation via interaction with proteins or RNAs, exhibiting various functions. The expression...

  • Review
  • Open Access
194 Citations
10,028 Views
44 Pages

LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms

  • Eleonora A. Braga,
  • Marina V. Fridman,
  • Alexey A. Moscovtsev,
  • Elena A. Filippova,
  • Alexey A. Dmitriev and
  • Nikolay E. Kushlinskii

23 November 2020

Ovarian cancer (OvCa) develops asymptomatically until it reaches the advanced stages with metastasis, chemoresistance, and poor prognosis. Our review focuses on the analysis of regulatory long non-coding RNAs (lncRNAs) competing with protein-coding m...

  • Review
  • Open Access
4 Citations
3,194 Views
23 Pages

Non-coding RNAs (ncRNAs) play diverse roles in regulating cellular processes and have been implicated in pathological conditions, including cancer, where interactions between ncRNAs play a role. Relevant here are (i) microRNAs (miRNAs), mainly known...

  • Article
  • Open Access
7 Citations
4,988 Views
17 Pages

The lncRNA 44s2 Study Applicability to the Design of 45-55 Exon Skipping Therapeutic Strategy for DMD

  • Elena Gargaun,
  • Sestina Falcone,
  • Guilhem Solé,
  • Julien Durigneux,
  • Andoni Urtizberea,
  • Jean Marie Cuisset,
  • Sofia Benkhelifa-Ziyyat,
  • Laura Julien,
  • Anne Boland and
  • France Pietri-Rouxel
  • + 11 authors

In skeletal muscle, long noncoding RNAs (lncRNAs) are involved in dystrophin protein stabilization but also in the regulation of myocytes proliferation and differentiation. Hence, they could represent promising therapeutic targets and/or biomarkers f...

  • Article
  • Open Access
5 Citations
2,823 Views
16 Pages

8 December 2022

Pulmonary arterial hypertension (PAH) is a pulmonary vascular disease characterized by pulmonary vascular remodeling and right heart enlargement the pathogenesis of PAH is complicated; no biologic-based therapy is available for the treatment of PAH,...

  • Feature Paper
  • Review
  • Open Access
38 Citations
6,633 Views
35 Pages

Regulation of Long Non-Coding RNAs by Plant Secondary Metabolites: A Novel Anticancer Therapeutic Approach

  • Mohammad Reza Kalhori,
  • Hamid Khodayari,
  • Saeed Khodayari,
  • Miko Vesovic,
  • Gloria Jackson,
  • Mohammad Hosein Farzaei and
  • Anupam Bishayee

13 March 2021

Long non-coding RNAs (lncRNAs) are a class of non-coding RNAs that play an essential role in various cellular activities, such as differentiation, proliferation, and apoptosis. Dysregulation of lncRNAs serves a fundamental role in the progression and...

  • Review
  • Open Access
1 Citations
2,042 Views
33 Pages

Landscape of Noncoding RNA in the Hypoxic Tumor Microenvironment

  • Lianfeng Gong,
  • Chuanxin Zou,
  • Haixia Zhang,
  • Fei Yang,
  • Gui Qi and
  • Zhaowu Ma

24 January 2025

Amidst the prevalent and notable characteristic of a hypoxic microenvironment present in the majority of solid tumors, a burgeoning number of studies have revealed the significance of noncoding RNAs (ncRNAs) in hypoxic tumor regions. The transcriptom...

  • Review
  • Open Access
8 Citations
3,254 Views
18 Pages

Prostate cancer (PC) is a common malignancy and is one of the leading causes of cancer-related death in men worldwide. Osteosarcoma (OS) is the most common bone cancer, representing 20–40% of all bone malignancy cases. Cancer metastasis is a pr...

  • Review
  • Open Access
4 Citations
1,723 Views
18 Pages

LncRNAs Regulate Vasculogenic Mimicry in Human Cancers

  • Eloísa Ibarra-Sierra,
  • Mercedes Bermúdez,
  • Carlos Esteban Villegas-Mercado,
  • Macrina B. Silva-Cázares and
  • César López-Camarillo

20 April 2025

Vasculogenic mimicry (VM) has recently been discovered as an alternative mechanism for nourishing cancer cells in vivo. During VM, tumor cells align and organize themselves into three-dimensional (3D) channel-like structures to transport nutrients an...

  • Article
  • Open Access
3 Citations
2,526 Views
15 Pages

Profiling Plasma Extracellular Vesicle Metabotypes and miRNAs: An Unobserved Clue for Predicting Relapse in Patients with Early-Stage NSCLC

  • Vivi Bafiti,
  • Eleni Thanou,
  • Sotiris Ouzounis,
  • Athanasios Kotsakis,
  • Vasilis Georgoulias,
  • Evi Lianidou,
  • Theodora Katsila and
  • Athina Markou

5 November 2024

Background and Objective: Lung cancer, the second most prevalent cancer globally, poses significant challenges in early detection and prognostic assessment. Despite advancements in targeted therapies and immunotherapy, the timely identification of re...

  • Feature Paper
  • Review
  • Open Access
31 Citations
4,906 Views
12 Pages

29 April 2021

LncRNA PVT1 (plasmacytoma variant translocation 1) has become a staple of the lncRNA profile in patients with renal cell carcinoma (RCC). Common dysregulation in renal tumors outlines the essential role of PVT1 in the development of RCC. There is alr...

  • Article
  • Open Access
641 Views
26 Pages

Targeting Pan-Cancer Stemness: Core Regulatory lncRNAs as Novel Therapeutic Vulnerabilities

  • Shengcheng Deng,
  • Yufan Yang,
  • Dapeng Gao,
  • Jiajun Gao and
  • Yuanyan Xiong

2 December 2025

Tumor stemness represents a key biological process that drives tumor progression and therapeutic resistance across various cancer types. To systematically elucidate the regulatory roles of long non-coding RNAs (lncRNAs) in this process, we integrated...

  • Article
  • Open Access
4 Citations
2,554 Views
16 Pages

Arrhythmogenic right ventricular cardiomyopathy (ARVC) can lead to sudden cardiac death and life-threatening heart failure. Due to its high fatality rate and limited therapies, the pathogenesis and diagnosis biomarker of ARVC needs to be explored urg...

  • Commentary
  • Open Access
8 Citations
6,485 Views
8 Pages

The Missing “lnc” between Genetics and Cardiac Disease

  • Maral Azodi,
  • Rick Kamps,
  • Stephane Heymans and
  • Emma Louise Robinson

Cardiovascular disease (CVD) is one of the biggest threats to public health worldwide. Identifying key genetic contributors to CVD enables clinicians to assess the most effective treatment course and prognosis, as well as potentially inform family me...

  • Review
  • Open Access
18 Citations
6,247 Views
25 Pages

Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs

  • Eleonora A. Braga,
  • Marina V. Fridman,
  • Alexey M. Burdennyy,
  • Elena A. Filippova,
  • Vitaly I. Loginov,
  • Irina V. Pronina,
  • Alexey A. Dmitriev and
  • Nikolay E. Kushlinskii

7 November 2022

A decrease in the miR-124 expression was observed in various epithelial cancers. Like a classical suppressor, miR-124 can inhibit the translation of multiple oncogenic proteins. Epigenetic mechanisms play a significant role in the regulation of miR-1...

  • Review
  • Open Access
6 Citations
4,620 Views
28 Pages

LncRNA: A Potential Target for Host-Directed Therapy of Candida Infection

  • Ye Wang,
  • Hongdan Xu,
  • Na Chen,
  • Jin Yang and
  • Hongmei Zhou

Despite various drugs work against Candida, candidiasis represents clinical management challenges worldwide due to the rising incidence and recurrence rate, as well as epidemics, of new drug-resistant pathogens. Recent insights into interactions betw...

  • Review
  • Open Access
35 Citations
5,937 Views
22 Pages

Exploring the Role of Non-Coding RNAs in the Pathophysiology of Systemic Lupus Erythematosus

  • Mohammad Taheri,
  • Reyhane Eghtedarian,
  • Marcel E. Dinger and
  • Soudeh Ghafouri-Fard

22 June 2020

Systemic lupus erythematosus (SLE) is a chronic immune-related disorder designated by a lack of tolerance to self-antigens and the over-secretion of autoantibodies against several cellular compartments. Although the exact pathophysiology of SLE has n...

  • Article
  • Open Access
75 Citations
6,584 Views
14 Pages

Multiple Layers of CDK5R1 Regulation in Alzheimer’s Disease Implicate Long Non-Coding RNAs

  • Marco Spreafico,
  • Barbara Grillo,
  • Francesco Rusconi,
  • Elena Battaglioli and
  • Marco Venturin

Cyclin-dependent kinase 5 regulatory subunit 1 (CDK5R1) gene encodes for p35, the main activator of Cyclin-dependent kinase 5 (CDK5). The active p35/CDK5 complex is involved in numerous aspects of brain development and function, and its deregulation...

  • Article
  • Open Access
52 Citations
6,577 Views
19 Pages

Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia

  • Patrick Connerty,
  • Ernest Moles,
  • Charles E. de Bock,
  • Nisitha Jayatilleke,
  • Jenny L. Smith,
  • Soheil Meshinchi,
  • Chelsea Mayoh,
  • Maria Kavallaris and
  • Richard B. Lock

Standard of care therapies for children with acute myeloid leukemia (AML) cause potent off-target toxicity to healthy cells, highlighting the need to develop new therapeutic approaches that are safe and specific for leukemia cells. Long non-coding RN...

  • Article
  • Open Access
10 Citations
3,414 Views
21 Pages

Liquid lncRNA Biopsy for the Evaluation of Locally Advanced and Metastatic Squamous Cell Carcinomas of the Head and Neck

  • Izabela Łasińska,
  • Tomasz Kolenda,
  • Kacper Guglas,
  • Magda Kopczyńska,
  • Joanna Sobocińska,
  • Anna Teresiak,
  • Norbert Oksza Strzelecki,
  • Katarzyna Lamperska,
  • Andrzej Mackiewicz and
  • Jacek Mackiewicz

16 September 2020

Background: Long non-coding RNA (lncRNA) are RNA molecules that are more than 200 nucleotides long and have the ability to modify the activity of genes. They can be found in both healthy and cancer tissues, as well as in plasma, saliva and other bodi...

  • Review
  • Open Access
32 Citations
6,170 Views
34 Pages

The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer

  • Han Yeoung Lee,
  • Seung Wan Son,
  • Sokviseth Moeng,
  • Soo Young Choi and
  • Jong Kook Park

Cancer is a global health concern, and the prognosis of patients with cancer is associated with metastasis. Multistep processes are involved in cancer metastasis. Accumulating evidence has shown that cancer cells acquire the capacity of anoikis resis...

  • Article
  • Open Access
1,102 Views
17 Pages

29 April 2025

Prostate cancer (PCa) is the most frequently diagnosed malignancy in the male genitourinary tract. However, the regulatory mechanism of competitive endogenous RNAs (ceRNAs) in PCa remains unclear. In this study, we first performed immune scores of mR...

  • Review
  • Open Access
18 Citations
4,677 Views
20 Pages

MicroRNAs and Long Noncoding RNAs as Novel Therapeutic Targets in Estrogen Receptor-Positive Breast and Ovarian Cancers

  • Tushar Singh Barwal,
  • Uttam Sharma,
  • Sonali Bazala,
  • Ipsa Singh,
  • Manju Jain,
  • Hridayesh Prakash,
  • Shashank Shekhar,
  • Elise N. Sandberg,
  • Anupam Bishayee and
  • Aklank Jain

Aromatase inhibitors (AIs) such as anastrozole, letrozole, and exemestane have shown to prevent metastasis and angiogenesis in estrogen receptor (ER)-positive breast and ovarian tumors. They function primarily by reducing estrogen production in ER-po...

  • Article
  • Open Access
34 Citations
8,251 Views
16 Pages

MicroRNAs and Long Non-Coding RNAs as Potential Candidates to Target Specific Motifs of SARS-CoV-2

  • Lucia Natarelli,
  • Luca Parca,
  • Tommaso Mazza,
  • Christian Weber,
  • Fabio Virgili and
  • Deborah Fratantonio

18 February 2021

The respiratory system is one of the most affected targets of SARS-CoV-2. Various therapies have been utilized to counter viral-induced inflammatory complications, with diverse success rates. Pending the distribution of an effective vaccine to the wh...

  • Article
  • Open Access
10 Citations
3,518 Views
18 Pages

Association of Circular RNA and Long Non-Coding RNA Dysregulation with the Clinical Response to Immune Checkpoint Blockade in Cutaneous Metastatic Melanoma

  • Javier Oliver,
  • Juan Luis Onieva,
  • Maria Garrido-Barros,
  • Miguel-Ángel Berciano-Guerrero,
  • Alfonso Sánchez-Muñoz,
  • María José Lozano,
  • Angela Farngren,
  • Martina Álvarez,
  • Beatriz Martínez-Gálvez and
  • Isabel Barragán
  • + 4 authors

27 September 2022

Cutaneous melanoma (CM) is the most lethal form of skin cancer if it becomes metastatic, where treatment options and survival chances decrease dramatically. Immunotherapy treatments based on the immunologic checkpoint inhibitors programmed death cell...

  • Article
  • Open Access
4 Citations
1,183 Views
14 Pages

Regulation of lncRNA NUTM2A-AS1 and CCR3 in the Clinical Response to a Plant-Based Diet in Rheumatoid Arthritis: A Pilot Study

  • Mario Peña-Peña,
  • Javier González-Ramírez,
  • Elyzabeth Bermúdez-Benítez,
  • José L. Sánchez-Gloria,
  • Luis M. Amezcua-Guerra,
  • Claudia Tavera-Alonso,
  • Carlos A. Guzmán-Martín,
  • Leonor Jacobo-Albavera,
  • Luis H. Silveira-Torre and
  • Fausto Sánchez-Muñoz
  • + 1 author

22 May 2025

Background/Objectives: RA is a chronic autoimmune disease characterized by systemic inflammation and progressive joint damage. Plant-based dietary interventions have recently emerged as complementary anti-inflammatory therapy for active RA. However,...

  • Article
  • Open Access
1 Citations
1,263 Views
23 Pages

Childhood Asthma Biomarkers Derived from Plasma and Saliva Exosomal miRNAs

  • Abdelnaby Khalyfa,
  • Mohit Verma,
  • Meghan M. Alexander,
  • Zhuanhong Qiao,
  • Tammy Rood,
  • Ragini Kapoor,
  • Trupti Joshi,
  • David Gozal and
  • Benjamin D. Francisco

Asthma, the most common chronic respiratory condition in children, involves airway inflammation, hyper-responsiveness, and frequent exacerbation that worsen the airflow and inflammation. Exosomes, extracellular vesicles carrying microRNAs (miRNAs), p...

  • Article
  • Open Access
3 Citations
3,387 Views
17 Pages

16 February 2025

Lung cancer exhibits substantial inter- and intra-tumor heterogeneity, with features that present significant challenges in advancing biomarker discovery and the development of targeted therapeutics. To fill this gap, we employed single-cell RNA sequ...

  • Review
  • Open Access
71 Citations
6,944 Views
27 Pages

miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy

  • Maria Teresa Di Martino,
  • Caterina Riillo,
  • Francesca Scionti,
  • Katia Grillone,
  • Nicoletta Polerà,
  • Daniele Caracciolo,
  • Mariamena Arbitrio,
  • Pierosandro Tagliaferri and
  • Pierfrancesco Tassone

30 March 2021

Immunotherapy is presently one of the most promising areas of investigation and development for the treatment of cancer. While immune checkpoint-blocking monoclonal antibodies and chimeric antigen receptor (CAR) T-cell-based therapy have recently pro...

  • Article
  • Open Access
5 Citations
3,849 Views
18 Pages

4 January 2023

Hepatic fibrosis can develop into cirrhosis or even cancer without active therapy at an early stage. Long non-coding RNAs (lncRNAs) have been shown to be involved in the regulation of a wide variety of important biological processes. However, lncRNA...

  • Article
  • Open Access
33 Citations
4,583 Views
17 Pages

Male-Specific Long Noncoding RNA TTTY15 Inhibits Non-Small Cell Lung Cancer Proliferation and Metastasis via TBX4

  • I-Lu Lai,
  • Ya-Sian Chang,
  • Wen-Ling Chan,
  • Ya-Ting Lee,
  • Ju-Chen Yen,
  • Chin-An Yang,
  • Shih-Ya Hung and
  • Jan-Gowth Chang

Gender affects cancer susceptibility. Currently, there are only a few studies on Y chromosome-linked long noncoding RNAs (lncRNAs), and the potential association between lncRNAs and cancers in males has not been fully elucidated. Here, we examined th...

of 3